Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction. (Q43655204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Arturo Gonzalez-Quintela

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Fernández-Ovide E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Piñeiro J

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Nuñez R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

655-658

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

cites work

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Exercise-induced asthma: update on pathophysiology, clinical diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Airway Levels of Mast Cell—derived Mediators in Exercise-induced Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Exercise-induced asthma is not associated with mast cell activation or airway inflammation*

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Effect of long-term salmeterol treatment on exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962294-6

7 January 2021

10.1016/S1081-1206(10)62294-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11428738%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference